Related Experiment Video
Updated: Mar 19, 2026

05:44
Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
1.2K
Neurofibromatosis, Down's syndrome, and acquired abnormalities
Syed Yousuf Ali1, Vimala Manne2, Ranjit Manne3
1Department of Dermatology and STD, Shadan Institute of Medical Sciences, Hyderabad, Telangana, India.
Indian Dermatology Online Journal
|June 14, 2016
Summary
This case study highlights a rare patient with Down syndrome and neurofibromatosis type 1. The patient presented with multiple distinct conditions, emphasizing the complexity of co-occurring genetic disorders.
Area of Science:
- Genetics
- Dermatology
- Pediatrics
Background:
- Down syndrome (trisomy 21) is a genetic disorder associated with characteristic facial features, intellectual disability, and developmental delays.
- Neurofibromatosis type 1 (NF1) is a genetic disorder characterized by café-au-lait spots, neurofibromas, and an increased risk of certain tumors.
- The simultaneous occurrence of these two distinct genetic conditions in a single patient is exceptionally rare.
Observation:
- The patient presented with a complex phenotype including keloid formation, a sebaceous cyst, and acanthosis nigricans.
- Associated findings included significant dental anomalies and ophthalmological defects.
- The combination of these dermatological and systemic findings in a patient with both Down syndrome and NF1 is highly unusual.
Findings:
- This report documents the rare coexistence of Down syndrome and neurofibromatosis type 1.
- The patient exhibited a constellation of cutaneous findings (keloid, sebaceous cyst, acanthosis nigricans) alongside developmental issues.
- The interplay between these two genetic conditions and their phenotypic manifestations is a key observation.
Implications:
- This case underscores the importance of comprehensive evaluation in patients with multiple rare genetic conditions.
- Understanding the phenotypic overlap and distinct features is crucial for accurate diagnosis and management.
- Further research may elucidate potential genetic interactions or shared pathways contributing to complex presentations.
Related Concept Videos
Meiosis I
221.3K
Meiosis is a carefully orchestrated set of cell divisions, the goal of which—in humans—is to produce haploid sperm or eggs, each containing half the number of chromosomes present in somatic cells elsewhere in the body. Meiosis I is the first such division, and involves several key steps, among them: condensation of replicated chromosomes in diploid cells; the pairing of homologous chromosomes and their exchange of information; and finally, the separation of homologous chromosomes by...
221.3K
Neurulation
47.1K
Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the...
47.1K
Nondisjunction
83.2K
During meiosis, chromosomes occasionally separate improperly. This occurs due to failure of homologous chromosome separation during meiosis I or failed sister chromatid separation during meiosis II. In some species, notably plants, nondisjunction can result in an organism with an entire additional set of chromosomes, which is called polyploidy. In humans, nondisjunction can occur during male or female gametogenesis and the resulting gametes possess one too many or one too few chromosomes.
83.2K
Nondisjunction
5.6K
Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers. Nondisjunction is common during anaphase I or anaphase II of meiosis. Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold...
5.6K
Karyotyping
69.8K
Overview
69.8K
Teratogenicity
4.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K

